Women want to know when it is appropriate to take a drug for osteoporosis, and which treatments are safe and effective. History has shown that preventing loss of bone mineral density in women who are otherwise at low risk of experiencing a fracture is dangerous.
Ipriflavone is an herbal medicine made from a hormone found in soy plants that has a similar chemical structure to human estrogen. Ipriflavone supplements are said to increase calcium absorption and decrease the breakdown of bones; however, there is currently a lack of research supporting this claim.
The National Women’s Health Network believes women have a right to know the potential benefits and risks of osteoporosis treatment, so we took a firsthand look at the evidence. We’ve compiled a quick fact sheet about the drug so you can get the unbiased truth.
Osteoporosis is a disease that causes your bones to lose tissue and become weak and fragile, potentially leading to bone fractures. Prevention and treatment methods can help inhibit fractures and decrease the severity of osteoporosis.
I have been treated with Aclasta for the last four years. My doctor wants to switch me to Prolia. He told me research has shown that using the same drug reduces its effectiveness. Is it true that Aclasta may lose effectiveness over extended use?
Women continue to experience gaps in healthcare access for a variety of issues, and we advocate for changes in the healthcare system that would remedy this. Bisphosphonate use, however, is one time when less really is more.
Reclast is one of eight FDA approved bisphosphonates. Bisphosphonates are a type of drug commonly used for osteoporosis treatment and prevention.
Is Fosteum safe and a good alternative for treating osteoporosis?
The NWHN acknowledges the overbearing influence pharmaceutical companies have on doctors and patients. This issue arises for those diagnosed with high bone fracture risk. Women are specifically targeted since they’re five times more likely to be diagnosed than men.
Bisphosphonate use for prevention has declined in recent years – and that’s a victory! But we’re concerned that a recent article in the Wall Street Journal with the misleading title “More Support for Osteoporosis Drugs: The benefits of bisphosphonates outweigh the risks for many patients” encourages the overuse of drugs that have not proven safe or effective as a preventive measure for women.